Internal Safety Override
- Status: active for local use.
- Keep operation local by default. Do not read secrets or transmit repository content externally without explicit opt-in.
- Audit categories: secrets.
FDA Consultant Specialist
FDA regulatory consulting for medical device manufacturers covering submission pathways, Quality System Regulation (QSR), HIPAA compliance, and device cybersecurity requirements.
Table of Contents
FDA Pathway Selection
Determine the appropriate FDA regulatory pathway based on device classification and predicate availability.
Decision Framework
Predicate device exists?
├── YES → Substantially equivalent?
│ ├── YES → 510(k) Pathway
│ │ ├── No design changes → Abbreviated 510(k)
│ │ ├── Manufacturing only → Special 510(k)
│ │ └── Design/performance → Traditional 510(k)
│ └── NO → PMA or De Novo
└── NO → Novel device?
├── Low-to-moderate risk → De Novo
└── High risk (Class III) → PMA
Pathway Comparison
| Pathway |
When to Use |
Timeline |
Cost |
| 510(k) Traditional |
Predicate exists, design changes |
90 days |
$21,760 |
| 510(k) Special |
Manufacturing changes only |
30 days |
$21,760 |
| 510(k) Abbreviated |
Guidance/standard conformance |
30 days |
$21,760 |
| De Novo |
Novel, low-moderate risk |
150 days |
$134,676 |
| PMA |
Class III, no predicate |
180+ days |
$425,000+ |
Pre-Submission Strategy
- Identify product code and classification
- Search 510(k) database for predicates
- Assess substantial equivalence feasibility
- Prepare Q-Sub questions for FDA
- Schedule Pre-Sub meeting if needed
Reference: See fda_submission_guide.md for pathway decision matrices and submission requirements.
510(k) Submission Process
Workflow
Phase 1: Planning
├── Step 1: Identify predicate device(s)
├── Step 2: Compare intended use and technology
├── Step 3: Determine testing requirements
└── Checkpoint: SE argument feasible?
Phase 2: Preparation
├── Step 4: Complete performance testing
├── Step 5: Prepare device description
├── Step 6: Document SE comparison
├── Step 7: Finalize labeling
└── Checkpoint: All required sections complete?
Phase 3: Submission
├── Step 8: Assemble submission package
├── Step 9: Submit via eSTAR
├── Step 10: Track acknowledgment
└── Checkpoint: Submission accepted?
Phase 4: Review
├── Step 11: Monitor review status
├── Step 12: Respond to AI requests
├── Step 13: Receive decision
└── Verification: SE letter received?
Required Sections (21 CFR 807.87)
| Section |
Content |
| Cover Letter |
Submission type, device ID, contact info |
| Form 3514 |
CDRH premarket review cover sheet |
| Device Description |
Physical description, principles of operation |
| Indications for Use |
Form 3881, patient population, use environment |
| SE Comparison |
Side-by-side comparison with predicate |
| Performance Testing |
Bench, biocompatibility, electrical safety |
| Software Documentation |
Level of concern, hazard analysis (IEC 62304) |
| Labeling |
IFU, package labels, warnings |
| 510(k) Summary |
Public summary of submission |
Common RTA Issues
| Issue |
Prevention |
| Missing user fee |
Verify payment before submission |
| Incomplete Form 3514 |
Review all fields, ensure signature |
| No predicate identified |
Confirm K-number in FDA database |
| Inadequate SE comparison |
Address all technological characteristics |
QSR Compliance
Quality System Regulation (21 CFR Part 820) requirements for medical device manufacturers.
Key Subsystems
| Section |
Title |
Focus |
| 820.20 |
Management Responsibility |
Quality policy, org structure, management review |
| 820.30 |
Design Controls |
Input, output, review, verification, validation |
| 820.40 |
Document Controls |
Approval, distribution, change control |
| 820.50 |
Purchasing Controls |
Supplier qualification, purchasing data |
| 820.70 |
Production Controls |
Process validation, environmental controls |
| 820.100 |
CAPA |
Root cause analysis, corrective actions |
| 820.181 |
Device Master Record |
Specifications, procedures, acceptance criteria |
Design Controls Workflow (820.30)
Step 1: Design Input
└── Capture user needs, intended use, regulatory requirements
Verification: Inputs reviewed and approved?
Step 2: Design Output
└── Create specifications, drawings, software architecture
Verification: Outputs traceable to inputs?
Step 3: Design Review
└── Conduct reviews at each phase milestone
Verification: Review records with signatures?
Step 4: Design Verification
└── Perform testing against specifications
Verification: All tests pass acceptance criteria?
Step 5: Design Validation
└── Confirm device meets user needs in actual use conditions
Verification: Validation report approved?
Step 6: Design Transfer
└── Release to production with DMR complete
Verification: Transfer checklist complete?
CAPA Process (820.100)
- Identify: Document nonconformity or potential problem
- Investigate: Perform root cause analysis (5 Whys, Fishbone)
- Plan: Define corrective/preventive actions
- Implement: Execute actions, update documentation
- Verify: Confirm implementation complete
- Effectiveness: Monitor for recurrence (30-90 days)
- Close: Management approval and closure
Reference: See qsr_compliance_requirements.md for detailed QSR implementation guidance.
HIPAA for Medical Devices
HIPAA requirements for devices that create, store, transmit, or access Protected Health Information (PHI).
Applicability
| Device Type |
HIPAA Applies |
| Standalone diagnostic (no data transmission) |
No |
| Connected device transmitting patient data |
Yes |
| Device with EHR integration |
Yes |
| SaMD storing patient information |
Yes |
| Wellness app (no diagnosis) |
Only if stores PHI |
Required Safeguards
Administrative (§164.308)
├── Security officer designation
├── Risk analysis and management
├── Workforce training
├── Incident response procedures
└── Business associate agreements
Physical (§164.310)
├── Facility access controls
├── Workstation security
└── Device disposal procedures
Technical (§164.312)
├── Access control (unique IDs, auto-logoff)
├── Audit controls (logging)
├── Integrity controls (checksums, hashes)
├── Authentication (MFA recommended)
└── Transmission security (TLS 1.2+)
Risk Assessment Steps
- Inventory all systems handling ePHI
- Document data flows (collection, storage, transmission)
- Identify threats and vulnerabilities
- Assess likelihood and impact
- Determine risk levels
- Implement controls
- Document residual risk
Reference: See hipaa_compliance_framework.md for implementation checklists and BAA templates.
Device Cybersecurity
FDA cybersecurity requirements for connected medical devices.
Premarket Requirements
| Element |
Description |
| Threat Model |
STRIDE analysis, attack trees, trust boundaries |
| Security Controls |
Authentication, encryption, access control |
| SBOM |
Software Bill of Materials (CycloneDX or SPDX) |
| Security Testing |
Penetration testing, vulnerability scanning |
| Vulnerability Plan |
Disclosure process, patch management |
Device Tier Classification
Tier 1 (Higher Risk):
- Connects to network/internet
- Cybersecurity incident could cause patient harm
Tier 2 (Standard Risk):
- All other connected devices
Postmarket Obligations
- Monitor NVD and ICS-CERT for vulnerabilities
- Assess applicability to device components
- Develop and test patches
- Communicate with customers
- Report to FDA per guidance
Coordinated Vulnerability Disclosure
Researcher Report
↓
Acknowledgment (48 hours)
↓
Initial Assessment (5 days)
↓
Fix Development
↓
Coordinated Public Disclosure
Reference: See device_cybersecurity_guidance.md for SBOM format examples and threat modeling templates.
Resources
scripts/
| Script |
Purpose |
fda_submission_tracker.py |
Track 510(k)/PMA/De Novo submission milestones and timelines |
qsr_compliance_checker.py |
Assess 21 CFR 820 compliance against project documentation |
hipaa_risk_assessment.py |
Evaluate HIPAA safeguards in medical device software |
references/
| File |
Content |
fda_submission_guide.md |
510(k), De Novo, PMA submission requirements and checklists |
qsr_compliance_requirements.md |
21 CFR 820 implementation guide with templates |
hipaa_compliance_framework.md |
HIPAA Security Rule safeguards and BAA requirements |
device_cybersecurity_guidance.md |
FDA cybersecurity requirements, SBOM, threat modeling |
fda_capa_requirements.md |
CAPA process, root cause analysis, effectiveness verification |
Usage Examples
# Track FDA submission status
python scripts/fda_submission_tracker.py /path/to/project --type 510k
# Assess QSR compliance
python scripts/qsr_compliance_checker.py /path/to/project --section 820.30
# Run HIPAA risk assessment
python scripts/hipaa_risk_assessment.py /path/to/project --category technical
1---2name: fda-consultant-specialist3description: FDA regulatory consultant for medical device companies. Provides 510(k)/PMA/De Novo pathway guidance, QSR (21 CFR 820) compliance, HIPAA assessments, and device cybersecurity. Use when user mentions FDA submission, 510(k), PMA, De Novo, QSR, premarket, predicate device, substantial equivalence, HIPAA medical device, or FDA cybersecurity.4---56## Internal Safety Override78- Status: active for local use.9- Keep operation local by default. Do not read secrets or transmit repository content externally without explicit opt-in.10- Audit categories: secrets.1112# FDA Consultant Specialist1314FDA regulatory consulting for medical device manufacturers covering submission pathways, Quality System Regulation (QSR), HIPAA compliance, and device cybersecurity requirements.1516## Table of Contents1718- [FDA Pathway Selection](#fda-pathway-selection)19- [510(k) Submission Process](#510k-submission-process)20- [QSR Compliance](#qsr-compliance)21- [HIPAA for Medical Devices](#hipaa-for-medical-devices)22- [Device Cybersecurity](#device-cybersecurity)23- [Resources](#resources)2425---2627## FDA Pathway Selection2829Determine the appropriate FDA regulatory pathway based on device classification and predicate availability.3031### Decision Framework3233```34Predicate device exists?35├── YES → Substantially equivalent?36│ ├── YES → 510(k) Pathway37│ │ ├── No design changes → Abbreviated 510(k)38│ │ ├── Manufacturing only → Special 510(k)39│ │ └── Design/performance → Traditional 510(k)40│ └── NO → PMA or De Novo41└── NO → Novel device?42 ├── Low-to-moderate risk → De Novo43 └── High risk (Class III) → PMA44```4546### Pathway Comparison4748| Pathway | When to Use | Timeline | Cost |49|---------|-------------|----------|------|50| 510(k) Traditional | Predicate exists, design changes | 90 days | $21,760 |51| 510(k) Special | Manufacturing changes only | 30 days | $21,760 |52| 510(k) Abbreviated | Guidance/standard conformance | 30 days | $21,760 |53| De Novo | Novel, low-moderate risk | 150 days | $134,676 |54| PMA | Class III, no predicate | 180+ days | $425,000+ |5556### Pre-Submission Strategy57581. Identify product code and classification592. Search 510(k) database for predicates603. Assess substantial equivalence feasibility614. Prepare Q-Sub questions for FDA625. Schedule Pre-Sub meeting if needed6364**Reference:** See [fda_submission_guide.md](references/fda_submission_guide.md) for pathway decision matrices and submission requirements.6566---6768## 510(k) Submission Process6970### Workflow7172```73Phase 1: Planning74├── Step 1: Identify predicate device(s)75├── Step 2: Compare intended use and technology76├── Step 3: Determine testing requirements77└── Checkpoint: SE argument feasible?7879Phase 2: Preparation80├── Step 4: Complete performance testing81├── Step 5: Prepare device description82├── Step 6: Document SE comparison83├── Step 7: Finalize labeling84└── Checkpoint: All required sections complete?8586Phase 3: Submission87├── Step 8: Assemble submission package88├── Step 9: Submit via eSTAR89├── Step 10: Track acknowledgment90└── Checkpoint: Submission accepted?9192Phase 4: Review93├── Step 11: Monitor review status94├── Step 12: Respond to AI requests95├── Step 13: Receive decision96└── Verification: SE letter received?97```9899### Required Sections (21 CFR 807.87)100101| Section | Content |102|---------|---------|103| Cover Letter | Submission type, device ID, contact info |104| Form 3514 | CDRH premarket review cover sheet |105| Device Description | Physical description, principles of operation |106| Indications for Use | Form 3881, patient population, use environment |107| SE Comparison | Side-by-side comparison with predicate |108| Performance Testing | Bench, biocompatibility, electrical safety |109| Software Documentation | Level of concern, hazard analysis (IEC 62304) |110| Labeling | IFU, package labels, warnings |111| 510(k) Summary | Public summary of submission |112113### Common RTA Issues114115| Issue | Prevention |116|-------|------------|117| Missing user fee | Verify payment before submission |118| Incomplete Form 3514 | Review all fields, ensure signature |119| No predicate identified | Confirm K-number in FDA database |120| Inadequate SE comparison | Address all technological characteristics |121122---123124## QSR Compliance125126Quality System Regulation (21 CFR Part 820) requirements for medical device manufacturers.127128### Key Subsystems129130| Section | Title | Focus |131|---------|-------|-------|132| 820.20 | Management Responsibility | Quality policy, org structure, management review |133| 820.30 | Design Controls | Input, output, review, verification, validation |134| 820.40 | Document Controls | Approval, distribution, change control |135| 820.50 | Purchasing Controls | Supplier qualification, purchasing data |136| 820.70 | Production Controls | Process validation, environmental controls |137| 820.100 | CAPA | Root cause analysis, corrective actions |138| 820.181 | Device Master Record | Specifications, procedures, acceptance criteria |139140### Design Controls Workflow (820.30)141142```143Step 1: Design Input144└── Capture user needs, intended use, regulatory requirements145 Verification: Inputs reviewed and approved?146147Step 2: Design Output148└── Create specifications, drawings, software architecture149 Verification: Outputs traceable to inputs?150151Step 3: Design Review152└── Conduct reviews at each phase milestone153 Verification: Review records with signatures?154155Step 4: Design Verification156└── Perform testing against specifications157 Verification: All tests pass acceptance criteria?158159Step 5: Design Validation160└── Confirm device meets user needs in actual use conditions161 Verification: Validation report approved?162163Step 6: Design Transfer164└── Release to production with DMR complete165 Verification: Transfer checklist complete?166```167168### CAPA Process (820.100)1691701. **Identify**: Document nonconformity or potential problem1712. **Investigate**: Perform root cause analysis (5 Whys, Fishbone)1723. **Plan**: Define corrective/preventive actions1734. **Implement**: Execute actions, update documentation1745. **Verify**: Confirm implementation complete1756. **Effectiveness**: Monitor for recurrence (30-90 days)1767. **Close**: Management approval and closure177178**Reference:** See [qsr_compliance_requirements.md](references/qsr_compliance_requirements.md) for detailed QSR implementation guidance.179180---181182## HIPAA for Medical Devices183184HIPAA requirements for devices that create, store, transmit, or access Protected Health Information (PHI).185186### Applicability187188| Device Type | HIPAA Applies |189|-------------|---------------|190| Standalone diagnostic (no data transmission) | No |191| Connected device transmitting patient data | Yes |192| Device with EHR integration | Yes |193| SaMD storing patient information | Yes |194| Wellness app (no diagnosis) | Only if stores PHI |195196### Required Safeguards197198```199Administrative (§164.308)200├── Security officer designation201├── Risk analysis and management202├── Workforce training203├── Incident response procedures204└── Business associate agreements205206Physical (§164.310)207├── Facility access controls208├── Workstation security209└── Device disposal procedures210211Technical (§164.312)212├── Access control (unique IDs, auto-logoff)213├── Audit controls (logging)214├── Integrity controls (checksums, hashes)215├── Authentication (MFA recommended)216└── Transmission security (TLS 1.2+)217```218219### Risk Assessment Steps2202211. Inventory all systems handling ePHI2222. Document data flows (collection, storage, transmission)2233. Identify threats and vulnerabilities2244. Assess likelihood and impact2255. Determine risk levels2266. Implement controls2277. Document residual risk228229**Reference:** See [hipaa_compliance_framework.md](references/hipaa_compliance_framework.md) for implementation checklists and BAA templates.230231---232233## Device Cybersecurity234235FDA cybersecurity requirements for connected medical devices.236237### Premarket Requirements238239| Element | Description |240|---------|-------------|241| Threat Model | STRIDE analysis, attack trees, trust boundaries |242| Security Controls | Authentication, encryption, access control |243| SBOM | Software Bill of Materials (CycloneDX or SPDX) |244| Security Testing | Penetration testing, vulnerability scanning |245| Vulnerability Plan | Disclosure process, patch management |246247### Device Tier Classification248249**Tier 1 (Higher Risk):**250- Connects to network/internet251- Cybersecurity incident could cause patient harm252253**Tier 2 (Standard Risk):**254- All other connected devices255256### Postmarket Obligations2572581. Monitor NVD and ICS-CERT for vulnerabilities2592. Assess applicability to device components2603. Develop and test patches2614. Communicate with customers2625. Report to FDA per guidance263264### Coordinated Vulnerability Disclosure265266```267Researcher Report268 ↓269Acknowledgment (48 hours)270 ↓271Initial Assessment (5 days)272 ↓273Fix Development274 ↓275Coordinated Public Disclosure276```277278**Reference:** See [device_cybersecurity_guidance.md](references/device_cybersecurity_guidance.md) for SBOM format examples and threat modeling templates.279280---281282## Resources283284### scripts/285286| Script | Purpose |287|--------|---------|288| `fda_submission_tracker.py` | Track 510(k)/PMA/De Novo submission milestones and timelines |289| `qsr_compliance_checker.py` | Assess 21 CFR 820 compliance against project documentation |290| `hipaa_risk_assessment.py` | Evaluate HIPAA safeguards in medical device software |291292### references/293294| File | Content |295|------|---------|296| `fda_submission_guide.md` | 510(k), De Novo, PMA submission requirements and checklists |297| `qsr_compliance_requirements.md` | 21 CFR 820 implementation guide with templates |298| `hipaa_compliance_framework.md` | HIPAA Security Rule safeguards and BAA requirements |299| `device_cybersecurity_guidance.md` | FDA cybersecurity requirements, SBOM, threat modeling |300| `fda_capa_requirements.md` | CAPA process, root cause analysis, effectiveness verification |301302### Usage Examples303304```bash305# Track FDA submission status306python scripts/fda_submission_tracker.py /path/to/project --type 510k307308# Assess QSR compliance309python scripts/qsr_compliance_checker.py /path/to/project --section 820.30310311# Run HIPAA risk assessment312python scripts/hipaa_risk_assessment.py /path/to/project --category technical313```